Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

In this retrospective cohort study, tirzepatide dispensations were found to have increased significantly following approval ...

Pfizer has terminated the development of its oral obesity candidate danuglipron after a patient on a clinical trial with the ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...

One solution some policymakers may try is restricting the number of people on Medicaid who can use the pricey drugs -- ...

Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...